ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency microbiology neuroscience immunology evolution

Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011 | 10+ min read
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
NIH Is Advised To Expand Its International Activities
Thomas Durso | Mar 2, 1997 | 9 min read
Sidebar: Advisory Panel's Recommendations to NIH But budget concerns may force the agency's heralded Fogarty Center to stand pat A comparatively small proposed budget increase for the center that coordinates international programs of the National Institutes of Health may prevent any significant expansion of its global efforts in the near future. A report submitted last fall by an external advisory panel recommended "a strengthening of international activities" at NIH (see list of recommendatio
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011 | 9 min read
By Gayatri Vedantam and Glenn S. Tillotson Wrestling with Recurrent Infections Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection. photoillustration by Sean Mccabe; Science Photo Library (boy); Sebastian Kaulitzki/ Istockphoto.com (Intestines); Olena Timashova/Istockphoto.com (Green bacteria); Jiri Flogel/Istockphoto.com (Blue bacteria) As infectiou
Deliberating Over Danger
The Scientist | Apr 1, 2012 | 10+ min read
The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

Run a Search

ADVERTISEMENT